BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019531

« Back to Dashboard

NDA 019531 describes NUTRILIPID 20%, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the NUTRILIPID 20% profile page.

The generic ingredient in NUTRILIPID 20% is soybean oil. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for 019531
Tradename:NUTRILIPID 20%
Applicant:B Braun
Ingredient:soybean oil
Formulation / Manufacturing:see details
Pharmacology for NDA: 019531
Suppliers and Packaging for NDA: 019531
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NUTRILIPID 10% soybean oil INJECTABLE;INJECTION 019531 NDA B. Braun Medical Inc. 0264-4460 0264-4460-00 8 CARTON in 1 CASE (0264-4460-00) > 1 CONTAINER in 1 CARTON > 1000 mL in 1 CONTAINER
NUTRILIPID 10% soybean oil INJECTABLE;INJECTION 019531 NDA B. Braun Medical Inc. 0264-4460 0264-4460-10 12 CARTON in 1 CASE (0264-4460-10) > 1 CONTAINER in 1 CARTON > 500 mL in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10%
Approval Date:May 28, 1993TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20%
Approval Date:May 28, 1993TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.